Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
Martha Hickey(Royal Women's Hospital), Vered Stearns(Johns Hopkins University), Ann H. Partridge(Dana-Farber Cancer Institute), Christobel Saunders(Royal Women's Hospital), Hadine Joffe(Beth Israel Deaconess Medical Center), Nanette Santoro(University of Colorado Denver)
Cited by 112
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947
Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
|JNCI Journal of the National Cancer Institute|2003|850
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830